Assessment of the link between in utero exposure to 2-aminoanthracene (2AA) and type-1 diabetes (T1D) by unknown
RESEARCH ARTICLE Open Access
Assessment of the link between in utero
exposure to 2-aminoanthracene (2AA) and
type-1 diabetes (T1D)
Christopher A. Mays1, Daniel A. Hunter1, Wilson Yau2 and Worlanyo E. Gato1*
Abstract
Background: A recent diabetes report revealed an increased incidence in diabetes including type 1-diabetes (T1D).
The increase in the numbers of T1D incidences are thought to be related to environmental reasons such as the
exposure to environmental chemicals including arylamine 2-aminoanthracene (2AA). T1D is an autoimmune disease of
the pancreatic islet in which insulin-producing beta cells are destroyed by auto-reactive T-cells and monocytic cells.
Methods: The purpose of this study is to examine the extent to which 2AA exposure contributes to T1D. Three groups
of pregnant Sprague Dawley dams ingested various concentrations of dietary 2AA from gestation through the postnatal
period. A select number of cytokines and adipokines previously noted to play a significant role in inflammatory response
were analyzed in the pancreas of the pups for alteration. The anatomy of the pancreas was also evaluated to determine
any histological changes.
Results: Results showed over-expression of pro-inflammatory protein IL-6. Up-regulation of humoral genes IL-7 and IL-21
were also noted. Pathologic characterization showed no significant changes. Moreover, serum total protein was
significantly reduced in exposed groups. Elevated serum glucose concentration seems to correspond to slightly lower
insulin levels in serum. Cumulative neonatal weight gain analysis showed no major alterations between the control
and gestationally-exposed rats.
Conclusion: It appears that systemic effects of 2AA ingestion were mild in the neonates. Further assessments of pups
who lived longer than two weeks could be a useful way to measure the progression and possibly further support our
hypothesis that 2AA can lead to systemic effects that are indicative of inducing T1D.
Keywords: Type-1 diabetes (T1D), 2-aminoanthracene (2AA), Cytokines, Pancreas, Insulin levels
Background
Diabetes remained the 7th leading cause of death in
2010 due to the number of death certificates listing it as
the underlying cause of death [1]. The incidence of
diabetes in 2012 was 1.7 million and in 2010 it was 1.9
million. In the 2008–2009 report by the Centers for
Disease Control and Prevention, an estimated 18,436
people younger than 20 years in the U.S. were newly
diagnosed with type-1 diabetes (T1D) annually. This
estimation is based on the demographics of the US
population taking into account socioeconomic state,
urbanization, age, and gender contributions to diabetes
prevalence [2].
T1D is an unpreventable, autoimmune disease of the
islet of Langerhans by which insulin-producing beta cells
are destroyed by auto-reactive T-cells and monocytic
cells [3]. The pancreas contains 5 types of cells: α, β, δ,
ε, and PP (pancreatic polypeptide) cells. Eighty percent
of the pancreatic cells in rodents are β-cells which are
the primary sources of insulin production [4]. Type-1
diabetes is a progressive disease whereby the β cells are
gradually destroyed after the manifestation of inflamed
islets during an autoimmune response. It is unclear if
β-cell apoptosis leads to an autoimmune response or if
an autoimmune response leads to β-cell apoptosis, but it* Correspondence: wgato@georgiasouthern.edu1Assistant Professor of Biochemistry, Department of Chemistry, Georgia
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is known that cytokines play an essential role because
they recruit immune cells [5].
This disease is triggered in two different ways: during
injury/infection to the pancreas or during natural β-cell
death through organ remodeling. In an injury or infec-
tion to the pancreas, macrophages enter the area and
cause an inflammatory reaction. The pro-inflammatory
reaction signals macrophages and T cells. The T cells
that are products of the immune response attack the β
cells that produce insulin. The dysregulation of the
excretion of autolytic cells, for reasons unknown, is the
cause of continued destruction of the β-cells. Organ
remodeling is performed through natural physiological
death, which does not cause an inflammatory response.
However, if these cells are not excreted properly they
can be released, resembling unwanted materials, and
produce a pathogen-induced inflammatory response.
The cause behind this autoimmune response has not
been understood very well [6]. Nevertheless, T1D is a
disease by which the pancreas is not able to produce or
secrete enough insulin to metabolize glucose within the
body and this makes the organism insulin dependent.
Clinical research has shown that instances of β-cell
destruction are associated with a decline in insulin
secretion [7, 8].
Many factors such as obesity, genetic predisposition,
and environmental pollutants [9] can cause a person
to become more susceptible to developing T1D. Also
tumor necrosis factor-alpha (TNFα) and IL-1β, which
are pro-inflammatory cytokines are increased in the
pancreas of obese mice [7]. An exogenous factor such
as exposure to polycyclic aromatic hydrocarbons
(PAHs) can catalyze inflammatory events within an
organism. For instance, application of a PAH, 2-
aminoanthracene (2AA) to the skin amplified dermal
inflammation [8].
In this project, we study the correlation between a
PAH named 2AA and T1D. 2AA belongs to a class of
PAHs and it is a carcinogen employed in the manu-
facturing of dyes, drugs, inks, and agricultural
chemicals. It can be found in emissions from domes-
tic heating, tobacco smoke, and automobiles. It is
more common in colder climates and winter seasons
due to increased use of heating and coal. This
pollutant can be extracted from the yards of homes
that live near industrial plants that process creosote
or coal [10–12].
It is prudent that we continue to examine all possible
causes and the genetic basis of T1D. The purpose of this
study is to examine any link between 2AA ingestion in
dams and T1D events in the neonates. We hypothesize
that dams that ingest 2AA during gestation will show




Nine timed pregnant dams (Day 1) were purchased from
Taconic Hudson, NY and assigned into dose regiments
of 0 mg/kg- (control-C), 50 mg/kg- (low dose-LD) and
100 mg/kg-diet (high dose-HD) 2AA to reflect environ-
mental exposure levels. It was previously estimated that
5 mg/week of 2AA consuming 0.0065% daily dietary
dose for one week [13]. Furthermore, chronic ingestion
of 2AA diet produced toxicological effects in the pan-
creas of rats [14]. The dams were fed 2AA contaminated
diet during the periods of gestation and postpartum. Rat
pups were sacrificed two weeks after postpartum. The
animals were housed at the Georgia Southern University
Animal Facility (1176A Biological Sciences Fieldhouse).
This facility is accredited by Association for Assessment
and Accreditation of Laboratory Animal Care (AAA-
LAC). The rats were treated according to the principles
outlined in the ILAR’s (Institute or Laboratory Animal
Research) Guide for Care and Use of Laboratory
Animals. Our protocols were reviewed and approved by
Institutional Animal Care and Use Committee (IACUC
protocol# I13010). We were careful to minimize the
number of animals employed in the research as well as
minimizing animal discomfort.
Preparation of diet containing 2AA
The 2AA (CAS# 613-13-8) with 98% purity was purchased
from Sigma Aldrich (St. Louis, MO) and used without
further purification. The appropriate amount of 2AA
was initially mixed with sucrose and shipped to
Harlan Laboratories Inc., Madison WI for incorpor-
ation into the Global Rodent Diet 2020. The base diet
2020X diet was designed to support gestation, lacta-
tion, and growth of the rats. Full details of the com-
position of the diet can be found on Envigo’s website
[15]. 2AA was incorporated into the 2020 diet to
ensure even distribution of the compound. A mixture
of sucrose and 2AA was premixed with some of the
powdered-diet and then mixed with the rest of the
diet for even distribution. Approximately 10% of
water was added to the diet and then it was pelleted.
Heat was not added during the pelleting process. The
diet was finally dried at 50 °C for 8 h in order to
reduce moisture and possible mold contamination.
The diet was then packaged and shipped. Control diet
was pelleted similar to 2AA adulterated diet to ensure
uniformity in diet preparation.
Histopathology
Pancreas of rat pups were fixed in 10% neutral buffered
formalin for at least 48 h, trimmed, routinely processed
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for histology, sectioned at 4-μm thickness, and stained
with hematoxylin and eosin.
Serum analysis of glucose, insulin, and total protein
Serum glucose was measured using a colorimetric method
developed for the RX Monza (Randox Laboratories Ltd,
Crumlin, UK) [16]. The method employs enzymatic oxida-
tion in the presence of glucose oxidase. The produced
hydrogen peroxide in the presence of peroxidase reacts
with phenol and 4-aminophenazone to yield a red to violet
product that has intensity proportional glucose concentra-
tion. Samples as well as standards were prepped according
to Randox’s Glucose (Glu-Pup - GL3815) kit instructions
and assayed at 505 nm.
Serum total protein (TP) was also determined using
Biuret Method modified for Randox Monza clinical analyzer
instrument (Randox Laboratories Ltd, Kearneysville, WV)
[17]. Similar to the glucose assay, TP (TP245, Randox
Laboratories Ltd, Kearneysville, WV) samples and standards
were prepared according to the guidelines provided by
Randox Laboratories.
The concentration of insulin in the serum was quanti-
fied using enzyme-linked immunosorbent assay (ELISA)
technique. Details of the experimental approach can be
found in the Ultra Sensitive Rat Insulin ELISA kit (Cat#
90060, Crystal Chem Inc, Downers Grove IL) and others
[18]. Briefly, insulin samples were bound to guinea pig
anti-insulin antibody on microplate and immobilized,
unbound materials were removed through washing, and
substrate solution was added to generate a colored prod-
uct and measured on a microplate reader (Spectra Max
190, Molecular Devices Corporation, Sunnyvale, CA,
USA) at 450 nm and 630 nm.
Quantification of selected mRNAs by RT-PCR
Gene transcripts that are important in mediating inflam-
matory and diabetic processes were quantified via quan-
titative qRT-PCR. The pro-inflammatory cytokines that
were examined were TNF-α, IL-1β, and IL-6. Further,
genes such as 1 L-21, IL-7, CD68, and CD14, which are
important for adaptive immunity, were also quantified.
In addition, two essential hormones (adiponectin and
leptin) secreted by adipose tissue were also measured.
β-Actin was quantified as a housekeeping gene. FASTA
mRNA sequences of these mRNA transcripts were
obtained from Rattus norvegicus using the National
Center for the Biotechnology Information (NCBI) data-
base. Forward and reverse primers for the genes were
then generated using NCBI Primer-Blast. Primers were
bought from Integrated DNA Technologies Inc (IDT),
Coralville IA USA.
An iScript cDNA synthesis kit was employed to
synthesize cDNAs from total RNA extracted using Rneasy
Plus Universal Mini by Qiagen. The cDNAs were combined
with primers and SsoFast EvaGreen supermix for the qPCR
reaction using β-actin as a control transcript. The product
was quantified via a Bio-Rad CFX96TM instrument
(Bio-Rad Laboratories Inc.) using the manufacturer’s guide-
lines. The normalized relative gene expression values were
determined via the delta Ct parameter.
Data analysis
Statistically significant differences in the aggregate pup
weights, total protein levels, serum and IL6 amount, glu-
cose, and insulin concentrations in control groups were
compared with 2AA exposed groups using analysis of
variance (ANOVA). Data were presented as mean ± SE.
Significant differences were indicated as either * P < 0.05
or ** P < 0.01.
Results
Effect of 2AA on neonatal weight
The body weights of the pups were recorded at the time
of birth and up until time of sacrifice (Fig. 1). No signifi-
cant differences in the weight of pups were observed
between the control and low dose animals. However, the
high dose group was marginally significantly lighter in
weight compared to the control group.
Analysis of total protein (TP) in the serum
Additional neonatal systemic toxic effects due to in utero
exposure of 2AA was determined through the serum
total protein concentration (Fig. 2). Significant reduction
or TP in the high dose group occurred.
Histological analysis of pancreas
Histopathologic characterization did not show signifi-
cant qualitative difference between in utero exposed
groups and non-treated rats (Fig. 3). This is expected
due to the short 2-week interval allowed to provide a
physical effect upon the pancreas.
Fig. 1 Mean weight of pups (n = 12–18) two weeks postpartum.
Average weight between control and 50 mg/kg 2AA was similar.
However, there was marginal P = 0.073671) reduction in the
100 mg/kg group
Mays et al. Journal of Diabetes & Metabolic Disorders  (2017) 16:5 Page 3 of 9
2AA effect on select inflammatory genes
The mRNA expression of selected genes (Table 1) were
chosen based on their role in the inflammatory process.
These were quantified in the pancreas using RT-PCR. The
majority of the genes maintained similar expression pat-
terns with the exception of IL-6, an inflammatory cytokine,
and IL-21 and IL-7 which are key factors in immune regu-
lation (Fig. 4). These genes are regulated in a dose
dependent manner. They are up-regulated in the pups that
were exposed to higher concentrations of 2AA in-utero.
Pup serum analysis
An evaluation of the pup serum between the in utero
exposed groups and non-treated rats was performed for
glucose and insulin utilizing colorimetric techniques. An
assessment of glucose and insulin concentrations
enabled the comparison on the systemic effects of ex-
posure to 2AA. The experimental groups do not appear
to show any significant difference between their insulin
concentrations (Fig. 5). However, there were significant
differences between the experimental groups and control
groups in assessment of glucose levels (Fig. 6). Insulin
concentrations plotted against glucose amounts displayed
an inverse relationship (Fig. 7). This might suggest a cellu-
lar glucose dependence on insulin levels.
Validation of gene expression data via protein
concentration of IL-6
Cytokine IL-6 concentrations were quantified in serum
to supplement the gene expression data due to the pleio-
tropic role that IL-6 plays in signaling pathways of acute
phase response genes (Fig. 8). The experimental groups
show significantly higher IL-6 concentrations than the
control group.
Discussion
The present study examines whether gestational expos-
ure to 2AA, a PAH, will cause susceptibility in neonates
towards the development of T1D. The primary predictor
of diabetes within an individual is hyperglycemia [19].
T1D and type-2 diabetes (T2D) can be differentiated by
quantifying the presence of ketones or testing the
presence of autoantibodies specific to insulin [20]. Insulin
is produced in the β cells of the islets of Langerhans. This
hormone is known to regulate glucose metabolism [21].
Insulin has three functions as glucose enters the body. It
Fig. 2 Total protein level (g/dL) ± standard error (SE) assay of the serum of Sprague Dawley rat offspring exposed to 2-AA in utero (n = 4) (P < 0.01).
Neonates were exposed to control (C – 0 mg/kg); low dose (LD – 50 mg/kg) and high dose (100 mg/kg)-2AA diet
Fig. 3 Histopathology pancreatic tissues (n = 7–10). Sprague Dawley dams ingested 0 mg/kg- (C Pup), 50 mg/kg- (LD Pup) and 100 mg/kg-2AA
(HD Pup) from gestation through postnatal period. Slides were H&E stained
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signals the cells of insulin-sensitive peripheral tissues to
absorb glucose, it acts on the liver to initiate glycogenesis,
and it inhibits the liver from performing gluconeogenesis
and glycogenolysis [22].
To examine the effect of 2AA on pups exposed to
2AA in utero, TP tests were undertaken. Significant re-
duction in TP levels within the HD experimental group
were noted. Albumins and globulins are the two most
abundant proteins present in a mammal and a shift in
TP is most likely a shift in the ratio of the two proteins
[23]. A high A/G ratio suggest an underproduction of
immunoglobulins which is commonly seen in genetic
deficiencies [24]. The HD group has a lower concentra-
tion of total protein which can be an indication of liver
or kidney disorder. Total protein assessments are non-
definitive and further tests are needed to aid in
determining the toxic effects. However, the assessment
is useful in providing preliminary evaluations.
The histological analysis of the pancreas showed a
negligible qualitative difference between the control and
experimental groups. As previously stated, it takes up
80% of pancreatic beta cells to be destroyed in order for
one to be formally diagnosed [7]. The pups in this study
were euthanized two weeks post-natal. The progression
to type-1 diabetes has yet to be observed, but may it take
more than two weeks before structural changes can be
detected within the pancreas via histology. On the other
hand, functional differences are evident within two
Fig. 4 The relative expression (ΔCq) of a select pancreatic mRNAs that play crucial roles in the cellular inflammatory process. Progeny underwent
in utero exposure to 2AA were 0 mg/kg 2AA diet (C- Control), 50 mg/kg diet (LD- Low Dose) and (100 mg/kg diet (HD- High Dose) from
Gestation through 14 days postnatal
Table 1 Nucleotide sequences designed as forward and reverse
primers of each specific gene
Gene Name Primer Sequence Products
size (bp)
Adiponectin Forward 5’- CCGCTTACATGTATCACTC-3’ 248
Reverse 5’- ATACTGGTCGTAGGTGAAGA - 3’
Leptin Forward 5’-CTGTCGTGACTGACTCTATG-3’ 588
Reverse 5’- GCTAAGTGATTTCTCATTCC -3’
CD68 Forward 5’- AAGTCCTAGTCCAAGCTCTA -3’ 311
Reverse 5’- AGGACACATTGTATTCCACT -3’
CD14 Forward 5’- CTCAGAATCTACCGACCA -3’ 867
Reverse 5’- ATAGATTGAGCGAGTTTAGC -3’
IL6 Forward 5’- GGAGTTTGTGAAGAACAACT -3’ 77
Reverse 5’- CTAGGGTTTCAGTATTGCTC -3’
TNFα Forward 5’- GAACACCCTGGTACTAACTC -3’ 519
Reverse 5- TAGATAAGGTACAGCCCATC -3’
IL7 Forward 5’- ATATCAGTGAGGAATTCAATG -3’ 134
Reverse 5’- TAGTCTCTTTAGGAAACATGG -3’
IL1β Forward 5’- TGATGTTCCCATTAGACAG -3’ 145
Reverse 5’- TACAAAGCTCATGGAGAATA -3’
IL21 Forward 5’- GAACAGCTGAAAATCTATGAG -3’ 219
Reverse 5’- CATGTGCCTCTGTTTATTTC -3’
β-Actin Forward 5’- CACCCGCGAGTACAAC -3’ 720
Reverse 5’- TACATAGCACAGCTTCTCTTT -3’
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weeks, as demonstrated here by the systemic effects in
specific gene expressions, glucose levels, and total
protein levels.
Results suggest that environmental factors can hinder
the action of insulin within the animal. The gene expres-
sion data of the rat offspring showed a concentration-
dependent mRNA targets due the consumption of 2AA.
Cytokines IL-6, IL-21, and IL-7 are up-regulated in rats
that consumed the highest concentration of 2AA. There
is evidence noting that IL-6 is present in many auto-
immune disorders because it can aid in the development
of the disease. This development may be induced
through IL-6 because it is responsible for initiating acute
phase responses, β-cell proliferation, and production of
autoantibodies [25]. IL-6 was up-regulated in many
diseases such as rheumatoid arthritis, multiple sclerosis,
and lupus [26]. However, IL-6 was not proven to be a
cause of type-1 diabetes because there were many other
proteins that serve as regulatory factors on the pancreatic
beta cells. Furthermore, IL-6 was shown to be present in
T2D malady, indicating this cytokine’s different regulatory
role via divergent mechanisms [26].
IL-21 was also up-regulated. IL-21 is an inflammatory
protein that signals via the JAK-STAT signaling pathway
utilizing STAT3, similar to IL-6, to drive IG production
and proliferation of T and B cells [2]. This finding
suggests that there might be a higher immune activity
within rodents whose mothers ingested 2AA. Further-
more, there have been studies showing rodents with IL-21
deficiency [2] have fewer and less functional TH17 helper
cells. These cells are crucial in T1D development. Our
results indicate fewer cases of inflamed insulin [3]. Simi-
larly, IL-7 was also up-regulated. IL-7 was shown to be
important for lymphoid cell survival and it plays a part in
the development of T and B cells. It binds to hepatocyte
growth factor to serve as a B cell growth stimulating factor
Fig. 5 Mean serum insulin concentration of Sprague Dawley rat offspring exposed to 2AA in-utero (n = 4). Neonates were systemically exposed
to control (C – 0 mg/kg); low dose (LD – 50 mg/kg) and high dose (100 mg/kg)-2AA diet during gestation. Insulin levels were not
significantly different though slightly lower in 2AA exposed groups
Fig. 6 Mean serum glucose concentration of Sprague Dawley rat offspring whose mothers ingested 2AA during gestation through postnatal
period. Neonates exposed to 2AA in utero had significantly higher (p < 0.05) serum glucose levels (n = 4). In utero exposure included
control (C – 0 mg/kg); low dose (LD – 50 mg/kg) and high dose (100 mg/kg)-2AA diet
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[27]. Previous studies introduced IL-7 antibodies into
non-obese diabetic mice and results appeared to reverse
the disease [28]. Consequently, IL-7 is also responsible for
stimulating expression of T-helper cells as well [28].
Though the expression of key inflammatory genes were
observed, it cannot be said at this point that 2AA exposure
causes T1D in rodents. This is primarily due to the fact that
the mechanism of the effects of 2-aminoanthracene has yet
to be elucidated. 2AA is within a class of arylamines and it
is known that they are mutagens that induce changes upon
DNA. However, a previous study showed the effects upon
pancreatic islets due to the prolonged exposure of 2AA,
approximately 80 days. The physical effects were the pro-
duction of intracellular vacuoles, destruction of proximal
acinar cells, and a reduced detection of insulin within these
cells. Studies have shown that vacuole formation may pre-
cede autophagic cell death through the upregulation of
Atg5 which acts upon Fas-associated protein with death
domain. This is a possible mechanism as to how 2AA can
lead to the pancreatic islet destruction [14, 29].
On the contrary, measurement of serum glucose
displayed a stronger support for the hypothesis under
study. Significant differences appeared between the con-
trol and gestational-exposed groups. One can infer that
prolonged exposure may lead to hyperglycemic condi-
tions. Clinical research has revealed that IL-6 can induce
glucagon secretion via direct stimulation of the pancreas’
α-cells or the brain during stimulation of the sympa-
thetic nervous system [30]. In other words, the induction
of IL-6 dependent glucagon dependent is also directly
correlated with the epinephrine produced. It is likely the
increased concentration of glucose IL-6 expression is
due to the two possible pathways for glucagon secretion
via IL-6 [30]. In addition, the LD group apparently has a
slightly higher concentration of glucose than the control
and HD animals.
With regards to the serum insulin levels, the experi-
mental rodents exhibited slightly lower concentrations
than the control group, although the reduction in insulin
amounts was not significant. Regarding lower insulin
Fig. 7 Comparison between mean serum insulin and glucose concentration of Sprague Dawley rat offspring exposed to 2-aminoanthrancene
in-utero. Serum samples taken 2 weeks postnatal and postweaning. (n = 4)
Fig. 8 Mean serum IL-6 concentrations of Sprague Dawley rat offspring exposed to 2-AA in-utero. Samples taken 2 weeks postnatal. Experimental
groups show a significant increase (p < .0.05) in IL-6 concentration
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concentration, hyperglycemic conditions can be the
consequence because higher levels of glucose may be due
to low concentrations of insulin in the cell. The findings
from the present study are similar to a previous investiga-
tion that assessed chronic exposure of 2AA [14]. In that
study, no significant change in the architecture of the pan-
creas or increased glucose levels were observed until day
63 after continuous 2AA dietary ingestion.
Conclusions
The present study examined whether gestational expos-
ure to a PAH named 2AA could lead to increased
susceptibility to T1D. Results indicate an over-expression
of pro-inflammatory and adaptive immunity gene tran-
scripts. Moreover, serum total protein was significantly
reduced in exposed groups. Elevated serum glucose con-
centration seems to correspond to slightly lower insulin
levels in serum. Cumulative neonatal weight gains and
histological analysis showed no major alterations between
the control and gestational-exposed rats. It appears that
systemic effects of 2AA ingestion were mild in the
neonates. Further assessments of pups who lived longer
than two weeks could be a useful way to measure the pro-
gression and possibly further support our hypothesis that
2AA can lead to systemic effects that are reflective of
inducing T1D.
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